Partner news
News
Partner news
Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform
Read full storyPartner news
Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program
Read full storyPartner news
BlackThorn Therapeutics Advances Phase 2 Clinical Development for Selective KOR Antagonist, BTRX-140, in Neuropsychiatric Disorders
Read full storyPartner news
Concerto HealthAI Establishes Real-World Data and AI Collaboration with Janssen
Read full storyPartner news
Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)
Read full storyPartner news
Memebox Closes $35 Million Financing to Fuel Innovation and Accelerate Company Growth
Read full storyPartner news
Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation
Read full storyPartner news
Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer
Read full storyPartner news
E-Scape Bio Appoints Dr. Carrolee Barlow as Chief Medical Officer
Read full storyPartner news
Carbon Announces JJDC as Additional Investor in $200 Million Funding Round
Read full storyPartner news
Nuevolution to receive license fee payment of USD 750,000
Read full storyPartner news
Alligator Bioscience to Receive USD 6 Million Milestone Payment from Janssen Coupled to the Decision to Initiate Combination Trial with ADC-1013
Read full storyPartner news
Verb Surgical Delivers Digital Surgery Prototype Demonstration to Collaboration Partners
Read full storyPartner news